Two Chinese traditional medicine research and development are transfer of more than one hundred million yuan 
 
 
Release date: March 6, 2014 
 

Source: health 

        The original title: two Chinese traditional medicine research and development are transfer of more than one hundred million yuan
Report from our correspondent reporter correspondent liu hua Cheng Shouqin recently from China pharmaceutical university science and technology conference in 2014, according to the school in transformation of scientific and technological innovation, scientific research has yielded fruitful results, two transfer fee are more than one hundred million yuan of traditional Chinese medicine research results particularly noteworthy. 
 
        According to the China pharmaceutical university vice-chancellor Kong Lingyi introduction, two transfer results achieved one hundred million yuan, a program called "ASD compounds AD TCM type of drug resistance. ASD for pentacyclic triterpene natural products, studies have shown that ASD for senile dementia has a dual role in the prevention and treatment of brain. Another for "new antitumor transfer DT - 13 new Chinese herbal category". The project director, China pharmaceutical university college of traditional Chinese medicine professor Yu Boyang, DT - 13 is the single compounds in traditional Chinese medicine radix ophiopogonis, research on radix commonly used traditional Chinese medicine (TCM) in the process of long-term research found the lead compounds DT - 13, the material was confirmed that low doses can kill the tumor, the effect of high dose and inhibiting tumor metastasis. At present, the drug at the pre-clinical stage.